Get startedLog in
    Picture of Britannia Life Sciences logo

    BLAB — Britannia Life Sciences Cashflow Statement

    0.000.00%
    ca flag iconLast trade - 00:00
    Consumer DefensivesSpeculativeMicro CapContrarian
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Britannia Life Sciences, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    2026
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-145.84-4.4-4.5613.1
    Depreciation
    Deferred Taxes
    Non-Cash Items16.1-4.455.340.81-12.9
    Discontinued Operations
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital0.461-0.4150.8851.07-1.57
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Payable / Accrued Expenses
    Change in Taxes Payable
    Other Operating Cash Flow
    Cash from Operating Activities2.81.222.09-2.62-1.16
    Capital Expenditures-0.087-0.342-0.337——
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.741-2.98-1.111.3-5.25
    Acquisition of Business
    Sale of Business
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities0.654-3.32-1.4411.3-5.25
    Financing Cash Flow Items-0.5960-1.8-1.790
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-2.582.95-1.97-2.17-0.111
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0.8030.967-1.286.53-6.52